Chevy Chase Trust Holdings LLC Sells 221 Shares of Teleflex Incorporated (NYSE:TFX)

Chevy Chase Trust Holdings LLC decreased its position in shares of Teleflex Incorporated (NYSE:TFX) by 0.8% in the 1st quarter, according to its most recent 13F filing with the SEC. The firm owned 26,028 shares of the medical technology company’s stock after selling 221 shares during the quarter. Chevy Chase Trust Holdings LLC owned approximately 0.06% of Teleflex worth $5,887,000 at the end of the most recent quarter.

Several other large investors also recently added to or reduced their stakes in the company. Kentucky Retirement Systems lifted its holdings in Teleflex by 1.1% during the 4th quarter. Kentucky Retirement Systems now owns 3,760 shares of the medical technology company’s stock worth $938,000 after purchasing an additional 42 shares in the last quarter. Venturi Wealth Management LLC grew its stake in Teleflex by 33.3% during the fourth quarter. Venturi Wealth Management LLC now owns 184 shares of the medical technology company’s stock valued at $46,000 after acquiring an additional 46 shares in the last quarter. KBC Group NV grew its stake in Teleflex by 1.8% during the fourth quarter. KBC Group NV now owns 3,173 shares of the medical technology company’s stock valued at $791,000 after acquiring an additional 55 shares in the last quarter. Lindbrook Capital LLC increased its holdings in Teleflex by 75.3% during the 4th quarter. Lindbrook Capital LLC now owns 135 shares of the medical technology company’s stock worth $34,000 after acquiring an additional 58 shares during the period. Finally, Wahed Invest LLC boosted its holdings in Teleflex by 8.9% in the 4th quarter. Wahed Invest LLC now owns 798 shares of the medical technology company’s stock valued at $199,000 after purchasing an additional 65 shares during the period. Hedge funds and other institutional investors own 95.62% of the company’s stock.

Teleflex Price Performance

NYSE TFX traded up $5.30 on Thursday, reaching $225.88. 33,255 shares of the company’s stock traded hands, compared to its average volume of 364,396. The stock has a market cap of $10.64 billion, a PE ratio of 35.41, a P/E/G ratio of 2.05 and a beta of 1.13. The company has a debt-to-equity ratio of 0.37, a current ratio of 2.51 and a quick ratio of 1.41. Teleflex Incorporated has a 12 month low of $177.63 and a 12 month high of $262.97. The stock has a 50-day simple moving average of $208.62 and a 200 day simple moving average of $224.04.

Teleflex (NYSE:TFX) last released its earnings results on Thursday, May 2nd. The medical technology company reported $3.21 EPS for the quarter, beating the consensus estimate of $3.07 by $0.14. The company had revenue of $737.80 million for the quarter, compared to analyst estimates of $726.85 million. Teleflex had a net margin of 9.82% and a return on equity of 14.78%. The firm’s quarterly revenue was up 3.8% compared to the same quarter last year. During the same quarter last year, the firm earned $3.09 EPS. As a group, research analysts predict that Teleflex Incorporated will post 13.75 earnings per share for the current year.

Teleflex Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Friday, June 14th. Stockholders of record on Wednesday, May 15th were paid a $0.34 dividend. This represents a $1.36 dividend on an annualized basis and a dividend yield of 0.60%. The ex-dividend date was Tuesday, May 14th. Teleflex’s dividend payout ratio (DPR) is presently 21.83%.

Wall Street Analyst Weigh In

A number of brokerages recently issued reports on TFX. Truist Financial increased their price objective on Teleflex from $219.00 to $235.00 and gave the stock a “hold” rating in a research report on Tuesday. Piper Sandler upgraded Teleflex from a “neutral” rating to an “overweight” rating and lifted their price target for the company from $205.00 to $245.00 in a research report on Monday, July 1st. Finally, Needham & Company LLC reissued a “hold” rating on shares of Teleflex in a report on Friday, May 3rd. Three analysts have rated the stock with a hold rating and six have given a buy rating to the company’s stock. According to MarketBeat, Teleflex currently has an average rating of “Moderate Buy” and a consensus target price of $262.43.

Teleflex Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.